Form 4: Organon & Co. CFO Matthew Walsh Reports Share Transactions

Chief Financial Officer Matthew M. Walsh reports acquisition and disposal of Organon & Co. common stock related to performance share units.

Summary

• On February 20, 2025, Matthew M. Walsh, CFO of Organon & Co., reported transactions involving the company's common stock.
• Walsh acquired 30,414 shares related to performance share units (PSUs) granted on August 09, 2022, under the company's 2021 Incentive Stock Plan.
• The performance-vesting restrictions were released following certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
• Additionally, 5,570 shares were acquired to cover dividend equivalents earned on the released PSUs.
• Walsh also disposed of 10,662 shares at $14.92 and 1,908 shares at $15.29.
• Following these transactions, Walsh beneficially owns 115,388 shares of Organon & Co. common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing reporting insider transactions. The release of PSUs suggests positive performance, but the sale of shares offsets this.

Positives

• The release of performance share units indicates that performance goals were met, as certified by the Talent Committee of Organon's Board of Directors.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders, providing insight into management's perspective on the company's stock.

Key Dates

Keywords

Organon & Co., Matthew M. Walsh, CFO, common stock, performance share units, Form 4, insider trading